| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/16/2003 | EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 04/16/2003 | EP1301505A2 Thiophene retinoids |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301495A2 Inhibitors of copper-containing amine oxidases |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 04/16/2003 | EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 04/16/2003 | EP1301181A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds |
| 04/16/2003 | EP1301173A1 A medicinal aerosol formulation |
| 04/16/2003 | EP1104288A4 Orally disintegrable tablet forming a viscous slurry |
| 04/16/2003 | EP1023279B1 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0942896B1 Substituted phenols and thiophenols useful as antioxidant agents |
| 04/16/2003 | EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | EP0642356B1 Antibodies to p-selectin and their uses |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 04/16/2003 | CN1411388A Methods for extraction and reaction using supercritical fluids |
| 04/16/2003 | CN1411372A Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/16/2003 | CN1411339A Antimicrobial composition comprising benzoic acid analog and metal salt |
| 04/16/2003 | CN1410124A Spray for treating sound of snoring |
| 04/16/2003 | CN1410109A Cordyceps and sichuan fritillaria cough suppressing paste and its preparation method |
| 04/16/2003 | CN1410105A Zibei Cough stopping granules and its preparation method |
| 04/16/2003 | CN1410091A External use medicine for treating allergic nasitis and preparing process thereof |
| 04/16/2003 | CN1410083A Yakong preparation (dental medicine) and its production method |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105705C Process for preparing heterocyclic amide derivative with specific physical status |
| 04/16/2003 | CN1105572C Compound rhododendron senivainii granule and its preparing method |
| 04/16/2003 | CN1105563C Asthma treating medicine and its production process |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548675 1-Cyclopropylcarbonyl-2-hydroxy(optional),4-isopropylbenzene used as starting materials for 1-((2-hydroxy(optional),4-alkylphenyl)carbonylalkyl-),4-(diphenylmethyl -)piperidine derivatives; antihistamines; antiallergens; bronchodilators |
| 04/15/2003 | US6548671 Quinoxalinyl amide derivatives |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump |
| 04/15/2003 | US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548489 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6546928 Metered dose inhaler for fluticasone propionate |
| 04/15/2003 | CA2381329C Medicaments |
| 04/15/2003 | CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines |
| 04/15/2003 | CA2053208C Hydroxyalkylquinoline ether acids as leukotriene antagonists |
| 04/15/2003 | CA2037975C 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| 04/12/2003 | CA2407214A1 Method of monitoring neuroprotective treatment |
| 04/11/2003 | WO2002032899A1 Novel anticholinergic agents that can be used as medicaments and method for the production thereof |
| 04/11/2003 | WO2002032898A2 Novel anticholinergics, method for the production thereof and use thereof as medicaments |
| 04/11/2003 | WO2002030928A1 Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| 04/11/2003 | WO2002030872A1 Novel aliphatic compounds, process for their preparation and their usage |
| 04/11/2003 | CA2425923A1 Novel aliphatic compounds, process for their preparation and their usage |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029205A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003029184A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 04/10/2003 | WO2003028759A1 Rsv gene expression vaccine |
| 04/10/2003 | WO2003028741A1 Composition of hypochlorous acid and its applications |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028713A2 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 04/10/2003 | WO2003028712A2 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases |
| 04/10/2003 | WO2003028705A1 Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/10/2003 | WO2003028626A2 Glucagon-like peptides (glp-1) and treatment of respiratory distress |
| 04/10/2003 | WO2003028527A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/10/2003 | WO2003015711A9 Combination motif immune stimulatory oligonucleotides with improved activity |
| 04/10/2003 | WO2003013564A3 An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 04/10/2003 | WO2002096467A3 Pharmaceutical use for secreted bacterial effector proteins |
| 04/10/2003 | WO2002094830A8 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 04/10/2003 | WO2002094203A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2003 | WO2002092064A3 Therapeutic method for inducing tolerance |
| 04/10/2003 | WO2002083103A3 Pharmaceutical product with reticulated crystalline microstructure |
| 04/10/2003 | WO2002083079A9 Aerosol compositions containing formoterol for delivery to the lungs via nebulization |
| 04/10/2003 | WO2002081668A8 Desaturase genes and uses thereof |
| 04/10/2003 | WO2002070540A3 Peptide deformylase inhibitors |
| 04/10/2003 | WO2002060412A3 Stabilised polymeric aerosols for pulmonary gene delivery |
| 04/10/2003 | WO2002059083A3 Novel compounds |
| 04/10/2003 | WO2002057460A3 Polynucleotides encoding human phosphatases |
| 04/10/2003 | WO2002050107A3 Streptococcus pyogenes antigens and corresponding dna fragments |
| 04/10/2003 | WO2002028889A3 Haemophilus influenzae antigens and corresponding dna fragments |